Artwork

Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S2 Ep15: PER®Spectives: Advancing Treatment in nAMD and DME with Novel Therapies

18:11
 
Share
 

Manage episode 398780516 series 2987803
Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This PER®Spectives™ podcast examines opportunities for extended treatment intervals associated with newer therapies for patients with neovascular age-related macular degeneration or diabetic macular edema. In this podcast, experts Arshad Khanani, MD, Ferhina Ali, MD, and Michael Singer, MD, offer real-world data and personal insights into the use of these agents — and corticosteroid implants for patients with DME — in the clinical setting.
Faculty:
Arshad M. Khanani, MD, MA, FASRS
Managing Partner
Director of Clinical Research and Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada, Reno School of Medicine
Reno, NV
Ferhina Ali, MD, MPH
Assistant Professor, Vitreoretinal Surgery
Vitreoretinal Surgery Consultant and Fellowship Advisor
Clinical Research Investigator and Vitreoretinal Specialist
Consultant Medical Director
Clinical Instructor
Westchester Medical Center Health Network
Hawthorne, NY
Michael A. Singer, MD
Clinical Associate Professor
University of Texas Health Science Center
Medical Center Ophthalmology Associates, Director of Clinical Research
San Antonio, TX
  continue reading

27 episodes

Artwork
iconShare
 
Manage episode 398780516 series 2987803
Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This PER®Spectives™ podcast examines opportunities for extended treatment intervals associated with newer therapies for patients with neovascular age-related macular degeneration or diabetic macular edema. In this podcast, experts Arshad Khanani, MD, Ferhina Ali, MD, and Michael Singer, MD, offer real-world data and personal insights into the use of these agents — and corticosteroid implants for patients with DME — in the clinical setting.
Faculty:
Arshad M. Khanani, MD, MA, FASRS
Managing Partner
Director of Clinical Research and Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada, Reno School of Medicine
Reno, NV
Ferhina Ali, MD, MPH
Assistant Professor, Vitreoretinal Surgery
Vitreoretinal Surgery Consultant and Fellowship Advisor
Clinical Research Investigator and Vitreoretinal Specialist
Consultant Medical Director
Clinical Instructor
Westchester Medical Center Health Network
Hawthorne, NY
Michael A. Singer, MD
Clinical Associate Professor
University of Texas Health Science Center
Medical Center Ophthalmology Associates, Director of Clinical Research
San Antonio, TX
  continue reading

27 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide